Latest news

New study demonstrates utility of RiiQ™

Belinda Esperson11 October 2024

Psychometric validation study of the RiiQ™: published

Belinda Esperson29 June 2023

RiiQ™ used in RSV vaccine trial to demonstrate effectiveness

Belinda Esperson11 April 2023

RiiQ™ increasingly being used as a primary endpoint

Belinda Esperson13 February 2023

New study using the RiiQ™ to assess clinical progression of COVID-19

Belinda Esperson3 May 2022

RiiQ™ application in Janssen CYPRESS trial supports understanding of vaccine effectiveness

Belinda Esperson8 December 2021

Recently published respiratory disease study using RiiQ™

Belinda Esperson6 December 2021

World’s first PROM for RSV trials – the RiiQ™

Belinda Esperson4 September 2021

flu-iiQ™ used in COVID-19 global survey

Belinda Esperson23 April 2020

Yes: the flu-iiQ™ is suitable for COVID-19 clinical trials

Belinda Esperson8 March 2020

Trials for Respiratory Syncytial Virus (RSV) now using flu-iiQ™

Laura Coutts29 May 2019

New translations added

Laura Coutts13 June 2018

Three more translations now available

Laura Coutts6 May 2016

Five new flu-iiQ™ translations now available

Laura Coutts2 December 2015

Flu-iiQ™ included in FDA sponsored global initiative that enables information system interoperability to improve medical research

Laura Coutts29 March 2015

flu-iiQ™ included in FDA sponsored global initiative that enables information system interoperability to improve medical research

Laura Coutts18 March 2015

flu-iiQ™ used in a global vaccine trial

Laura Coutts9 April 2014

Swedish and Spanish flu-iiQ™ now available

Laura Coutts14 January 2014

flu-iiQ™ at Options for the Control of Influenza VIII Conference in Cape Town

Laura Coutts18 August 2013

Use of the flu-iiQ™ in a recent large clinical study

Laura Coutts18 August 2013